TNF and autoimmune disease: Although immunosuppressors such as azathioprine, TNF blockers such as etanercept, and α4β7 integrin blocker (vedolizumab) have been used to treat autoimmune diseases, the fact that full efficacy is observed in only a fraction of patients supports the necessity of genomics-based precision medicine as an approach.